latest news releases from the newsroom
ICC Worldwide, Inc.
ICC Worldwide Announces Financial Results for Fiscal Year Ended September 30, 2008
CORONA DEL MAR, Calif., Jan. 13, 2009 (GLOBE NEWSWIRE) -- ICC Worldwide, Inc. (Pink Sheets:ICCW) today announced financial results for the fiscal year ended September 30, 2008. For the year, revenue was $255,588 from the company's continuing telecommunications wholesale operations and $1,149,163 from discontinued retail store operations for the same period. The retail stores were sold on October 31, 2008 following the end of the fiscal year. The Company incurred a net loss of $4,691,601 for the year ended September 30, 2008 including $1,977,141 in losses from the discontinued retail store operations.
Glancy Binkow & Goldberg LLP
Glancy Binkow & Goldberg LLP -- Representing Investors Who Purchased AtriCure, Inc. -- Announces Update to Shareholder Lawsuit -- ATRC
LOS ANGELES, Jan. 13, 2009 (GLOBE NEWSWIRE) -- Glancy Binkow & Goldberg LLP -- representing shareholders of AtriCure, Inc. -- announces 28 days remaining to move to be a lead plaintiff in the shareholder lawsuit. All persons or entities who purchased or otherwise acquired the securities of AtriCure, Inc. ("AtriCure" or the "Company") (Nasdaq:ATRC), between May 10, 2007 and October 31, 2008, inclusive (the "Class Period"), may move the Court not later than February 10, 2009, to serve as lead plaintiff; however, you must meet certain legal requirements.
Finkelstein Thompson LLP
Finkelstein Thompson LLP Announces Investigation of Advanced Medical Optics, Inc.
WASHINGTON, Jan. 13, 2009 (GLOBE NEWSWIRE) -- Finkelstein Thompson LLP is currently investigating potential shareholder claims for breach of fiduciary duty in connection with the proposed purchase of Advanced Medical Optics, Inc. ("Advanced Medical") (NYSE:EYE) by Abbott Laboratories ("Abbott Labs") (NYSE:ABT). Under the agreement announced today, Abbott Labs will pay roughly $1.36 billion and will assume certain debts, bringing the total value of the deal to approximately $2.8 billion. This represents a 12% discount from the Company's 52-week high of $24.90.
Xenith Bankshares, Inc.
Hampton Roads Bankshares Announces Expanded ATM Network
NORFOLK, Va., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Hampton Roads Bankshares, Inc. (Nasdaq:HMPR), the financial holding company for Bank of Hampton Roads, Gateway Bank & Trust Co. and Shore Bank, announced today that customers of each of its banks may use their ATM cards across the entire branch network without foreign use charges. Jack W. Gibson, the Vice Chairman and Chief Executive Officer of Hampton Roads Bankshares commented, "The more than 80 ATM locations that we can now offer our customers across our markets is one of the first of the many steps we are taking to offer our customers the broadest possible range of services and products and to continue to provide the best possible customer experience." Bank of Hampton Roads has ATM locations at each of its 18 branches in Chesapeake, Norfolk, Suffolk and Chesapeake, Virginia as well as Norfolk Scope and Chrysler Hall. Gateway Bank & Trust Co. has ATM locations at each of its 37 offices across North Carolina and Virginia as well as Green Gifford Chrysler Dodge Jeep on North Military Highway in Norfolk, Virginia. Shore Bank has ATM locations at each of its 8 branch locations, 6 Food Lion Stores and 8 Shore Stop Stores across the Eastern Shore of Maryland and Virginia as well as in both the Holiday Inn and Quality Inn in Ocean City, Maryland. A list of all ATM locations is available at any of the bank websites listed below.
Levi & Korsinsky, LLP
Levi & Korsinsky, LLP Investigates Breach of Fiduciary Duty by the Board of Advanced Medical Optics, Inc.
NEW YORK, Jan. 13, 2009 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP is investigating breaches of fiduciary duty and other violations of state law by the board of directors of Advanced Medical Optics, Inc. ("Advanced Medical" or the "Company") (NYSE:EYE) arising out of their attempt to sell the Company to Abbott Laboratories ("Abbott"). Under the terms of the agreement, shareholders of Advanced Medical will receive $22.00 cash for every share they hold of Advanced Medical, or $1.36 billion. The transaction appears to be unfair and undervalues the Company's shares given that Advanced Medical's shares traded as high as $23.31 per share as recently as September 2, 2008. Moreover, the present purported premium offer represents only a 2.5 multiplier from last year's sales, which is in line with multipliers on similar deals and therefore does not appear to represent any significant premium payable to Advanced Medical shareholders.
Maxim Integrated Products, Inc.
Maxim Schedules Conference Call for Second Quarter Financial Results
SUNNYVALE, Calif., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Maxim Integrated Products, Inc. (Nasdaq:MXIM) will be releasing financial results for the second quarter of its 2009 fiscal year on Thursday, January 29, 2009. The results will be released over GlobeNewswire at approximately 1:00 PM (PDT), after the close of the market on that date and will be posted on Maxim's website at www.maxim-ic.com/Investor